Summary
A CASE of malignant insulinoma was treated with streptozotocin intravenously and by coeliac axis infusion. Treatment was repeated over a period of two years, and the total dose was 82.5g. Several clinical remissions of hypoglycaemia were obtained despite the persistence of abnormally elevated plasma insulin levels. At necropsy tumour metastases within the liver were not necrotic. Severe medial degeneration of the lower abdominal aorta was present but the relationship of this change to intra-arterial infusion of the drug could not be established.
Similar content being viewed by others
References
Arnould, Y., Oooms, H. A. and Bastenie, P. A. 1969. Treatment of insuloma with streptozotocin. Lancet i, 1210.
Blackard, W. G., Garcia, A. R. and Brown, C. L. Jr. 1970. Effect of streptozotocin on qualitative aspects of plasma insulin in a patient with malignant islet cell tumour. J. Clin. Endocr., 31, 215.
Carter, S. K., Broder, L. and Friedman. 1971. Streptozotocin and malignant insulinoma. Ann. intern. Med. 74, 445.
Cunningham, G. R., Quickel, K. E. Jr. and Lebovitz, H. E. 1971. The use of insulin dynamics in the evaluation of streptozotocin therapy of malignant insulinomas. J. clin. Endocr. 33, 530.
Junod, A., Lambert, A. E., Orci, L., Pictet, R., Gonet, A. E. and Reynolds, A. E. 1967. Studies of the diabetogenic action of streptozotocin. Proc. Soc. exper. biol. Med. 126, 201.
Murray-Lyon, I. M., Eddleston, A. L. W. F., Williams, R., Brown, M., Hogbin, B. M., Bennett, A., Edwards, J. G. and Taylor, K. W. 1968. Treatment of multiple-hormone-producing islet cell tumour with streptozotocin. Lancet ii, 895.
Murray-Lyon, I. M., Cassar, J., Coulson, R., Williams, R., Ganguli, P. C., Edwards, J. C. and Taylor, K. W. 1971. Further studies on streptozotocin therapy for a multiple-hormone-producing islet cell carcinoma. Gut 12, 717.
Nieschlag, E., Wombacher, H., Koeger, F. J. und Habighorst, L. V. 1971. Therapie eines metastasierenden inzelzelltumors mit streptozotocin. Acta endocrinol. 67, 405.
Sadoff, L. 1969. Effects of streptozotocin in a patient with islet cell carcinoma. Diabetes 18, 675.
Sadoff, L. 1970. The nephrotoxicity of streptozotocin. Cancer Chemother. Rep. 54, 457.
Schreibman, P. H., de Koliren, L. G. and Arky, R. A. 1971. Malignant insulinoma treated with streptozotocin. Ann. intern. Med. 74, 399.
Smith, C. K., Stoll, R. W., Vance, J., Ricketts, H. and Williams, R. H. 1971. Treatment of malignant insulinoma with streptozotocin. Diabetologia 7, 118.
Stanley, N. N., Marks, V., Kreels, L. and McIntyre, N. 1970. Streptozotocin treatment of malignant islet cell tumour. Brit. med. J. iii, 562.
Taylor, S. G., Schwartz, T. B., Zannini, J. J. and Ryan, W. G. 1970. Streptozotocin therapy for malignant insulinoma. Arch. intern. Med. 126, 654.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
O'Donnell, J., Allen, I.V., Hunter, J.C. et al. Streptozotocin treatment for malignant insulinoma. Ir J Med Sci 143, 137–144 (1974). https://doi.org/10.1007/BF03004755
Issue Date:
DOI: https://doi.org/10.1007/BF03004755